Newsroom

GREENWICH, Conn.--(BUSINESS WIRE)--QXO, Inc. (NYSE: QXO) (the “Company” or “QXO”) today announced the pricing of its previously announced public offering of 31,645,570 shares of its common stock (the “Offering”) at a price to public of $23.80 per share. The Offering is expected to close on January 20, 2026, subject to customary closing conditions. QXO has granted the underwriter of the Offering an option to purchase up to an additional 4,746,835 shares of common stock at the public offering pri...

BENGALURU, India--(BUSINESS WIRE)--Okta, Inc., the leading independent identity company, is reinforcing its commitment to the Indian market with the launch of in-country Okta Platform tenants, delivering data residency and enhanced disaster recovery. It also helps enable highly regulated sectors—such as banking, financial services, insurance, and healthcare—to securely adopt AI and strengthen their defenses against advanced cyber threats. As enterprises in India accelerate their AI ambitions, s...

DALLAS--(BUSINESS WIRE)--Aethon Energy Management LLC (“Aethon”) today announced the formation of a Global Strategic Alliance with Mitsubishi Corporation (“Mitsubishi”), establishing a framework for collaboration on future commercial opportunities across energy transition and next-generation infrastructure projects on a global basis. The Global Strategic Alliance is intended to provide a platform for the parties to explore and evaluate potential projects in areas including liquefied natural gas...

TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that its wholly owned subsidiary, Mitsubishi Electric Intelligent Manufacturing Technology (China) Group Co., Ltd. in Suzhou, China, acquired a stake in ADT Technology Service (Suzhou) Co., Ltd., a Suzhou-based software developer with which the subsidiary had signed a collaboration agreement. By collaborating with ADTTech, which develops software for production planning, manufacturing management, quality contr...

OSAKA, Japan--(BUSINESS WIRE)--The English Ver of Fantôme Rapport launches Jan 16, 2026 (JST). A romantic horror mystery aboard a ghostly luxury liner, where bonds shape your fate....

SINGAPORE--(BUSINESS WIRE)--AM Best has maintained its outlook on India’s non-life insurance segment at stable, citing supportive macroeconomics, as well as insurance demand buttressed by regulatory initiatives and reforms. India’s non-life segment recorded mid-single-digit premium growth for the fiscal year ending 31 March 2025 (FY2025), according to the Best’s Market Segment Report, “Market Segment Outlook: India Non-Life Insurance.” Growth moderated relative to the prior year given the prici...

LOS ÁNGELES--(BUSINESS WIRE)--Xsolla, una empresa global de comercio de videojuegos que ayuda a los desarrolladores a implementar, desarrollar y monetizar sus juegos, ha anunciado hoy la implementación de un nuevo método de pago local en Uruguay: Mercado Pago. Esta nueva integración consolida la presencia de Xsolla en Latinoamérica, al permitirles a los desarrolladores ofrecerles a los jugadores experiencias de pago confiables que priorizan el sistema de pago con el celular en uno de los mercad...

LOS ANGELES--(BUSINESS WIRE)--A Xsolla, empresa multinacional de comércio de videogames que auxilia desenvolvedores no lançamento, crescimento e monetização de seus jogos, anunciou hoje o lançamento do Mercado Pago como um novo método de pagamento local no Uruguai. A integração reforça a presença da Xsolla na América Latina, permitindo que os desenvolvedores ofereçam experiências de pagamento confiáveis e otimizadas para dispositivos móveis aos jogadores em um dos mercados mais avançados digita...

米マサチューセッツ州レキシントン--(BUSINESS WIRE)--（ビジネスワイヤ） -- 免疫腫瘍学のイノベーションリーダーであるアジーナス（Nasdaq：AGEN）は、以前に公表したザイダス・ライフサイエンスとの戦略的提携の締結を発表しました。この契約は、アジーナスのボテンシリマブとバルスチリマブ（BOT+BAL）の免疫療法併用プログラムの世界的な開発と商業化の可能性を加速することを目的としています。 この提携により、アジーナスは米国において戦略的資本と長期にわたる生物製剤製造能力を獲得し、BOT+BAL 臨床開発、認可された早期のアクセス経路、および商業的供給の準備をサポートします。 提携の一環として、アジーナスはザイダスにインドとスリランカでBOTとBALを開発および商品化する独占権を付与し、アジーナスはこれらの地域での純売上高に応じてロイヤルティを受け取る権利を得ました。 2025年6月3日に発表されたこの提携には、主に以下の財務条件が含まれていました。 前払金：カリフォルニア州エメリービルとバークレーの生物製剤製造施設の譲渡に対して、アジーナスに7500万ドルの現金支...

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), líder en innovación en inmuno-oncología, anunció el día de hoy el cierre de su colaboración estratégica previamente anunciada con Zydus Lifesciences Ltd. El acuerdo tiene por objeto acelerar el desarrollo global y la posible comercialización del programa de combinación de inmunoterapias botensilimab y balstilimab (BOT+BAL) de Agenus. La colaboración proporciona a Agenus capital estratégico y capacidad de fabricación de productos bio...